Company Filing History:
2 out of 84 
2 out of 2 
1 out of 1 Years Active: 2022-2024
Title: Salvatore Pernagallo: Innovator in Nanosystems for Therapeutic Applications
Introduction
Salvatore Pernagallo is a notable inventor based in Granada, Spain. He has made significant contributions to the field of nanotechnology, particularly in the development of nanosystems for the controlled transport of active molecules. His work has implications for diagnostic, prognostic, and therapeutic purposes.
Latest Patents
Salvatore Pernagallo holds 3 patents. His latest patents include a nanoparticle system that consists of a polymer support or substrate in the form of nanoparticles. This system incorporates a hydrolase enzyme capable of degrading hyaluronic acid, along with one or more biologically and/or pharmacologically active molecules that are covalently bonded. The preparation process and its applications in the diagnostic, prognostic, and therapeutic fields are also disclosed in his patents.
Career Highlights
Throughout his career, Salvatore has worked with prominent companies such as Fidia Farmaceutici S.p.a. and Nanogetic S.l. His experience in these organizations has allowed him to refine his expertise in the field of pharmaceuticals and nanotechnology.
Collaborations
Salvatore has collaborated with notable individuals in his field, including Rosario Maria Sanchez Martin and Juan Diego Unciti Broceta. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Salvatore Pernagallo is a distinguished inventor whose work in nanosystems has the potential to revolutionize therapeutic applications. His patents and collaborations reflect his commitment to advancing medical science through innovative technologies.